These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cooperation between Fc gamma receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokine-primed human eosinophils. van der Bruggen T, Kok PT, Raaijmakers JA, Lammers JW, Koenderman L. J Immunol; 1994 Sep 15; 153(6):2729-35. PubMed ID: 8077677 [Abstract] [Full Text] [Related]
4. Priming of human eosinophils by platelet-activating factor enhances the number of cells able to bind and respond to opsonized particles. Blom M, Tool AT, Roos D, Verhoeven AJ. J Immunol; 1992 Dec 01; 149(11):3672-7. PubMed ID: 1431137 [Abstract] [Full Text] [Related]
6. Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors. Sun Q, Jones K, McClure B, Cambareri B, Zacharakis B, Iversen PO, Stomski F, Woodcock JM, Bagley CJ, D'Andrea R, Lopez AF. Blood; 1999 Sep 15; 94(6):1943-51. PubMed ID: 10477723 [Abstract] [Full Text] [Related]
12. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Warringa RA, Mengelers HJ, Kuijper PH, Raaijmakers JA, Bruijnzeel PL, Koenderman L. Blood; 1992 Apr 01; 79(7):1836-41. PubMed ID: 1558975 [Abstract] [Full Text] [Related]
13. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5. Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M. Immunol Lett; 2008 Jun 15; 118(1):88-95. PubMed ID: 18440651 [Abstract] [Full Text] [Related]
14. Cooperative effects of interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor: a new myeloid cell line inducible to eosinophils. Paul CC, Tolbert M, Mahrer S, Singh A, Grace MJ, Baumann MA. Blood; 1993 Mar 01; 81(5):1193-9. PubMed ID: 8443379 [Abstract] [Full Text] [Related]
16. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone. Hartnell A, Kay AB, Wardlaw AJ. Immunology; 1992 Dec 01; 77(4):488-93. PubMed ID: 1493920 [Abstract] [Full Text] [Related]
17. Interleukin-5, interleukin-3 and granulocyte-macrophage colony-stimulating factor prime actin-polymerization in human eosinophils: a study with hypodense and normodense eosinophils from patients with atopic dermatitis. Kaatz M, Berod L, Czech W, Idzko M, Lagadari M, Bauer A, Norgauer J. Int J Mol Med; 2004 Dec 01; 14(6):1055-60. PubMed ID: 15547673 [Abstract] [Full Text] [Related]
18. Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor induce adhesion and chemotaxis of human eosinophils via p38 mitogen-activated protein kinase and nuclear factor kappaB. Ip WK, Wong CK, Wang CB, Tian YP, Lam CW. Immunopharmacol Immunotoxicol; 2005 Dec 01; 27(3):371-93. PubMed ID: 16237950 [Abstract] [Full Text] [Related]
19. Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Coffer PJ, Schweizer RC, Dubois GR, Maikoe T, Lammers JW, Koenderman L. Blood; 1998 Apr 01; 91(7):2547-57. PubMed ID: 9516156 [Abstract] [Full Text] [Related]